Evaluating Violence Against Women Screening in Mexico

Yale University

Status: Completed

Conditions: Domestic Violence

Treatments: Behavioral: Integrated Screening

Study type: Interventional

Funder types: Other

Identifiers

NCT01661504

1202009793

Details and patient eligibility

About

The overall goal of this proposed study is to develop the state of knowledge in the area of gender-based violence and reproductive health by conducting a randomized controlled trial to improve the health care provider's capacity to screen for intimate partner violence and to mitigate associated risk among women health clinic patrons of reproductive age (ages18-44) with recent experiences of physical or sexual partner violence in Mexico City and its surrounding area.

The specific research objectives are as follows:

1. To increase mid-level health care providers' capacity to identify Intimate Partner Violence (IPV) and assist women with risk mitigation
2. Utilizing a randomized controlled trial, to assess the impact of an enhanced health care worker screening and counselling program on (a) past year severe IPV (sexual or physical), including severe IPV; (b) reproductive coercion (c) use of community-based resources and safety planning; and (d) quality of life; versus minimum standard of care
3. To qualitatively examine which programmatic components may serve as mechanisms for observed changes stated in the second objective
4. To synthesize study findings and a) create recommendations for clinic-based intervention programs to address IPV in low and middle income countries and b) disseminate information as reports, presentation, and peer-reviewed publications

Enrollment: 959 patients

Sex: Female

Ages: 18 to 44 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ages 18-44
• Currently in heterosexual relationship with a male partner
• Responds in affirmative to past year sexual or physical violence

Exclusion criteria

• Cognitive impairment (slurred speech, inability to follow directions)
• Seeking treatment for life threatening emergency care
• Intends to relocate within 2 years.

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

959 participants in 2 patient groups

Referral Card Only

No Intervention group

Description:

Women participants at control clinics will be given a referral card containing general information on IPV and a list of resources specific to their community

Integrated Screening

Experimental group

Description:

The intervention arm will consist of the following components (described in detail below): a) integrated IPV/Sexual and Reproductive Health Screening, b) supportive care, c) safety planning and harm reduction counseling, d) supported referrals, e) booster counseling sessions at 3 months post-baseline / initial counseling

Treatment:

Behavioral: Integrated Screening